Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NASDAQ:OPK)

6.87
Delayed Data
As of Sep 25
 +0.16 / +2.38%
Today’s Change
5.85
Today|||52-Week Range
12.15
-26.13%
Year-to-Date
Weekly CEO Buys Highlights
Sep 25 / GuruFocus News - Paid Partner Content
Is the Options Market Predicting a Spike in Opko Health (OPK) Stock?
Sep 12 / Zacks.com - Paid Partner Content
Weekly Top Insider Buys Highlight for the Week of Sept. 22
Sep 23 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close6.71
Today’s open6.68
Day’s range6.65 - 6.90
Volume7,470,501
Average volume (3 months)4,449,398
Market cap$3.8B
Dividend yield--
Data as of 4:00pm ET, 09/25/2017

Growth & Valuation

Earnings growth (last year)+16.67%
Earnings growth (this year)-283.33%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+148.44%
P/E ratioNM
Price/Sales4.19
Price/Book1.79

Competitors

 Today’s
change
Today’s
% change
PTLAPortola Pharmaceutic...-0.23-0.42%
CLVSClovis Oncology Inc-2.60-3.31%
PBYIPuma Biotechnology I...+1.40+1.34%
MNKMallinckrodt Plc+0.42+1.21%
Data as of 4:01pm ET, 09/25/2017

Financials

Next reporting dateNovember 13, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$1.2B
Annual profit (last year)-$25.1M
Net profit margin-2.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
CFO, Treasurer, &
Chief Accounting Officer
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts